Tschiersch J, Li W B, Meisenberg O
GSF--National Research Center for Environment and Health, Institute of Radiation Protection, D-85764 Neuherberg, Germany.
Radiat Prot Dosimetry. 2007;127(1-4):73-8. doi: 10.1093/rpd/ncm341. Epub 2007 Jul 18.
Increased concentrations of thoron (220Rn) and its progenies were recently measured in traditional residential dwellings and gave rise to concern about thoron dose assessment. A compartment model for the attached and unattached thoron progenies in the human body by inhalation was adapted, applied to individual measurements and examined in regard to model parameters. It was found that the lung dose is the dominant contribution to the thoron effective dose in spite of the transfer of 212Pb to other tissue. The organ equivalent dose and effective dose coefficients may change by about a factor of 2 within the 0.0-0.2 range of the unattached fraction. A decrease of the dissolution half-life of the inhaled particles in the lungs by a factor of 10 results in a decrease of the effective dose by <50%. Individual measurements of total concentration and unattached fraction result in a mean dose conversion factor of 1.3 Sv per Jhm(-3) and a mean annual dose to the residents of 11 mSv for permanent stay.
最近在传统住宅中测量到钍射气(220Rn)及其子体的浓度增加,这引发了对钍射气剂量评估的关注。通过吸入建立了人体中附着和未附着钍射气子体的隔室模型,将其应用于个体测量并对模型参数进行了检验。结果发现,尽管212Pb会转移到其他组织,但肺部剂量对钍射气有效剂量的贡献最大。在未附着部分的0.0 - 0.2范围内,器官等效剂量和有效剂量系数可能会改变约2倍。肺部吸入颗粒溶解半衰期降低10倍,有效剂量降低幅度小于50%。总浓度和未附着部分的个体测量结果得出平均剂量转换系数为每焦耳每小时立方米1.3 Sv,长期居住居民的年平均剂量为11 mSv。